Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DHEA supplementation: the claims in perspective.

Ewa Olech1, Joan T Merrill

  • 1Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation Oklahoma City, 73104, USA.

Cleveland Clinic Journal of Medicine
|December 1, 2005
PubMed
Summary

Dehydroepiandrosterone (DHEA) deficiency is linked to several diseases, but current evidence is insufficient to recommend DHEA supplements. More large-scale human studies are needed to confirm its effectiveness and safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adiposity-Associated Monocyte Costimulatory Programming in Rheumatoid Arthritis Identified by Single-Cell Transcriptomics.

medRxiv : the preprint server for health sciences·2026
Same author

Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026
Same author

"More guidelines than rules": reconsidering key gaps in the 2025 American College of Rheumatology treatment recommendations for systemic lupus erythematosus: comment on the article by Sammaritano et al.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.

Journal of clinical epidemiology·2026
Same author

Comparative Performance of LFA-REAL, SLEDAI, and BILAG for Detecting Clinically Meaningful Changes in Lupus Activity.

Arthritis care & research·2026
Same author

Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring.

Arthritis & rheumatology (Hoboken, N.J.)·2025

Area of Science:

  • Endocrinology
  • Neuroscience
  • Immunology

Background:

  • Dehydroepiandrosterone (DHEA) deficiency is associated with various health conditions.
  • These conditions include lupus erythematosus, diabetes mellitus, Alzheimer disease, and certain cancers.

Purpose of the Study:

  • To evaluate the current evidence regarding the efficacy of dehydroepiandrosterone (DHEA) supplementation.
  • To determine if DHEA supplementation is a viable treatment option for associated conditions.

Main Methods:

  • Review of observational clinical studies.
  • Analysis of laboratory experiments.
  • Assessment of existing human studies on DHEA.

Main Results:

  • DHEA deficiency shows correlations with lupus, diabetes, Alzheimer's, and cancers.
  • Preliminary studies suggest potential benefits of DHEA.
  • Insufficient evidence exists from large-scale human trials.

Conclusions:

  • Current evidence does not support routine dehydroepiandrosterone (DHEA) treatment.
  • Further large-scale human studies are required to establish efficacy and safety.
  • Concerns regarding supplement quality control and variable active ingredient amounts persist.

Related Experiment Videos